🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today, on #InternationalDayOfWomenAndGirlsInScience, we celebrate the countless contributions of #WomenInScience. Their work advances scientific discovery, drives innovation, and empowers the next generation of scientists. Thank you for shaping the future of science!

There is still time to join us today!

Acompañenos a aprender más sobre el cáncer y lo importante que es participar en la investigación para desbloquear nuevos descubrimientos y tratamientos! Registro: hubs.ly/Q0372L2p0

Behind every breakthrough is a dedicated team. Meet a few of our staff working to accelerate cancer discoveries! #CountMeIn #CancerResearch

Count Me In is dedicated to patient-driven colorectal cancer research that has the power to accelerate discoveries. If you have ever been diagnosed with CRC, you can join us in making a difference. Learn more this #ColorectalCancerAwarenessMonth at hubs.ly/Q038ZTZf0.

Did you know? Colorectal cancer is on the rise in younger adults, with cases in people under 50 increasing. Researchers are working to understand why - and patient-driven research can help. 🔬 Learn more and get involved: hubs.ly/Q038dpln0.

We're honored to launch our latest project on translocation renal cell carcinoma (tRCC) - a rare, aggressive kidney cancer. With few treatment options, the tRCC Project partners with patients, caregivers & advocates to drive research forward. Learn more: hubs.ly/Q03bhbST0

Count Me In tRCC Project is now enrolling patients with translocation renal cell carcinoma to help advance research and treatment. If you have patients who may be eligible, pls refer them to this initiative. visit trccproject.org.

Join us for a 1-hour session on Count Me In’s newest patient-partnered research initiative: the tRCC Project! Learn about its impact, patient collaboration, and next steps. Register now: trccproject.org #tRCC

CMI launched a research initiative for patients with translocation renal cell carcinoma (#tRCC). Physicians treating individuals with tRCC can help by sharing this opportunity with patients. Learn more at trccproject.org and request materials here: bit.ly/tRCCRequest

As #KidneyCancerAwarenessMonth ends, the need for research continues. We launched the tRCC Project to drive progress for this rare kidney cancer because every patient's unique experience matters. Join us in making a lasting impact: trccproject.org.

We hope you'll join us next week to learn more about our tRCC patient-partnered research project! Register at tRCCProject.org.

More impact, together! Count Me In is proud to join Broad Clinical Labs to expand access to research and center patients in biomedical discovery. Read more at the link below.

It’s #AYAware Week! 89,500 AYAs (15-39) are diagnosed with cancer each year in the U.S., yet they face higher drug costs, barriers to care, and are underrepresented in research. Join us in raising awareness & advocating for AYA cancer communities.

Wise words from Count Me In's dedicated Director of Operations, Diane, who brings her curiosity and drive to our operations every day - helping grow and scale our patient-partnered research efforts. See more on her journey: 🔗 broad.io/WISDiane

Today on World DNA Day, we celebrate the power of genomic data to drive discovery. Thank you to everyone in the Count Me In community who shares their data to help move cancer research forward. #WorldDNADay #CountMeIn

This #NationalCancerResearchMonth, we’re celebrating patient participation advancing research in rare cancers like tRCC, osteosarcoma, leiomyosarcoma, and PediHCC. Together, we’re building datasets that can drive discoveries. Learn more: joincountmein.org/scientific-res…

Integrating reporting for germline and tumor sequencing is key to equitable cancer care. Nature Medicine Commentary by members of PE-CGS advocates for integrated genetic reporting frameworks for a comprehensive genetic assessment. Read more: rdcu.be/enVCt

What is tRCC? In our latest video, experts break down this rare subtype of #KidneyCancer, which affects younger patients and requires a different approach to diagnosis and treatment. Watch now + explore the Rare Subtypes playlist: bit.ly/RareSubtypes #AcceleratingCures

Missed the live session? Watch the webinar recording at the link in our bio, introducing the tRCC Project- a patient-partnered research initiative focused on translocation renal cell carcinoma. #tRCC #PatientPartneredResearch #KidneyCancer